Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

And we wait.....

BearDownAZ

Jan 23, 2018 11:04AM

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: And we wait.....

in response to

And we wait.....

BearDownAZ

posted on Jan 23, 2018 02:26PM

....Why are we still waiting on the 10 MM share private placement that has been advertised by Zenith since October 2017 as coming soon?....

The November presentation says....

Enterprise
Value est.
$350 to $375MM USD
($3.00 USD/Share) est.

The December and January presentations say.....

Enterprise
Value est.
$350 to $375MM USD
($2.50 to $3.00 USD/share) est.

What's the reason for the share-price-estimate drop to a range? Perhaps it reflects some difficulty getting a higher, hoped-for private-placement share price, and/or ongoing negotiations, therefore delays?